NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.2 Drugs affecting the immune response > 8.2.4 Other immunomodulating drugs > Multiple sclerosis (relapsing) - teriflunomide NICE TAG TA303

Multiple sclerosis (relapsing) - teriflunomide NICE TAG TA303

1.1
Teriflunomide is recommended for treating adults with active relapsing–remitting multiple sclerosis (normally defined as 2 clinically significant relapses in the previous 2 years), only if

they do not have highly active or rapidly evolving severe relapsing–remitting multiple sclerosis and

the manufacturer provides teriflunomide with the discount agreed in the patient access scheme.

http://www.nice.org.uk/guidance/TA303

Site by Devopa
© Copyright 2019 NHS. All rights reserved.